1. Home
  2. XTNT vs CBAT Comparison

XTNT vs CBAT Comparison

Compare XTNT & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTNT
  • CBAT
  • Stock Information
  • Founded
  • XTNT N/A
  • CBAT 1999
  • Country
  • XTNT United States
  • CBAT China
  • Employees
  • XTNT N/A
  • CBAT N/A
  • Industry
  • XTNT Biotechnology: Biological Products (No Diagnostic Substances)
  • CBAT Industrial Machinery/Components
  • Sector
  • XTNT Health Care
  • CBAT Miscellaneous
  • Exchange
  • XTNT Nasdaq
  • CBAT Nasdaq
  • Market Cap
  • XTNT 110.6M
  • CBAT 90.4M
  • IPO Year
  • XTNT N/A
  • CBAT N/A
  • Fundamental
  • Price
  • XTNT $0.76
  • CBAT $0.88
  • Analyst Decision
  • XTNT
  • CBAT
  • Analyst Count
  • XTNT 0
  • CBAT 0
  • Target Price
  • XTNT N/A
  • CBAT N/A
  • AVG Volume (30 Days)
  • XTNT 389.4K
  • CBAT 605.6K
  • Earning Date
  • XTNT 11-11-2025
  • CBAT 11-10-2025
  • Dividend Yield
  • XTNT N/A
  • CBAT N/A
  • EPS Growth
  • XTNT N/A
  • CBAT N/A
  • EPS
  • XTNT N/A
  • CBAT N/A
  • Revenue
  • XTNT $127,766,000.00
  • CBAT $145,462,366.00
  • Revenue This Year
  • XTNT $13.03
  • CBAT N/A
  • Revenue Next Year
  • XTNT N/A
  • CBAT $60.02
  • P/E Ratio
  • XTNT N/A
  • CBAT N/A
  • Revenue Growth
  • XTNT 15.16
  • CBAT N/A
  • 52 Week Low
  • XTNT $0.33
  • CBAT $0.57
  • 52 Week High
  • XTNT $0.95
  • CBAT $1.28
  • Technical
  • Relative Strength Index (RSI)
  • XTNT 48.70
  • CBAT 42.87
  • Support Level
  • XTNT $0.73
  • CBAT $0.88
  • Resistance Level
  • XTNT $0.95
  • CBAT $0.94
  • Average True Range (ATR)
  • XTNT 0.07
  • CBAT 0.05
  • MACD
  • XTNT -0.01
  • CBAT -0.01
  • Stochastic Oscillator
  • XTNT 14.00
  • CBAT 19.25

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

Share on Social Networks: